Central Macular Thickness Monitoring after a Taxane-Based Therapy in Visually Asymptomatic Patients
Conclusion: Taxane-based chemotherapy regimens seem to increase macular thickness, with a relative sparing of the fovea, in patients without significant macular edema. Further research is required to better explain the pathophysiology and possible impact of this phenomenon.Chemotherapy 2017;62:199-204
Source: Chemotherapy - Category: Cancer & Oncology Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Alopecia | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Diabetes | Docetaxel | Endocrinology | Esophagus Cancer | Eyes | Opthalmology | Ovarian Cancer | Ovaries | Study | Taxotere